CIBC Private Wealth Group
ARCT icon

CIBC Private Wealth Group’s Arcturus Therapeutics ARCT Stock Holding History

CIBC Private Wealth Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39
Closed -$347 – 3090
2025
Q1 		$347 Hold
39
– – ﹤0.01% 2924
2024
Q4 		$739 Hold
39
– – ﹤0.01% 2823
2024
Q3 		$905 Hold
39
– – ﹤0.01% 2918
2024
Q2 		$841 Hold
39
– – ﹤0.01% 2924
2024
Q1 		$1.29K Buy
+39
New +$1.38K ﹤0.01% 2828

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

CIBC Private Wealth Group's ARCT Position: Q2 2025 in Review

CIBC Private Wealth Group sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 39 shares — an estimated $347 sold.

CIBC Private Wealth Group first reported a position in ARCT in Q1 2024 and held it in 5 quarters. The position peaked at $1.29K in Q1 2024. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • CIBC Private Wealth Group reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 39 Arcturus Therapeutics shares in Q2 2025, an estimated $347.
  • CIBC Private Wealth Group first reported a position in Arcturus Therapeutics in Q1 2024 and held it in 5 quarters.
  • CIBC Private Wealth Group's Arcturus Therapeutics position peaked at $1.29K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on CIBC Private Wealth Group's 13F filing for Q2 2025, filed 12 Aug 2025.